We are live on
!
Find out more
ZEAL
Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL
Delisted
ZEAL was delisted on the 29th of September, 2022.
12 hedge funds and large institutions have $16.8M invested in Zealand Pharma A/S American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
14% less funds holding
Funds holding: 14 → 12 (-2)
23% less capital invested
Capital invested by funds: $22M → $16.8M (-$5.14M)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$367K |
| 2 |
Morgan Stanley
New York
|
+$79.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$20.7K |
| 4 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
+$7.63K |
Top Sellers
| 1 |
BlackRock
New York
|
-$59.8K |
| 2 |
JCM
Jacobi Capital Management
Pittston,
Pennsylvania
|
-$28K |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$15.8K |
| 4 |
S
SignatureFD
Atlanta,
Georgia
|
-$5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$4.78K |